NASDAQ:RNXT • US75989R1077
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RENOVORX INC (RNXT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-17 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-08-25 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-06-05 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-05-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-28 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-04-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-27 | HC Wainwright & Co. | Initiate | Buy |
| 2024-12-10 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-09-12 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-06-17 | Ascendiant Capital | Initiate | Buy |
| 2024-02-02 | Alliance Global Partners | Initiate | Buy |
| 2023-11-15 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-08-18 | Roth MKM | Maintains | Buy -> Buy |
| 2021-11-01 | Roth Capital | Initiate | Buy |
| 2021-10-06 | Maxim Group | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 43K | 1.331M 2,995.35% | 4.254M 219.61% | 16.712M 292.85% | 54.495M 226.08% | 126.42M 131.98% | 265.34M 109.89% | 313.73M 18.24% | 333.87M 6.42% | 111.22M -66.69% | |||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.95M -75.49% | -11.396M -14.53% | -10.97M 3.74% | -12.334M -12.43% | -11.328M 8.15% | -3.109M 72.56% | 16.192M 620.87% | 69.47M 329.04% | 179.18M 157.92% | 235.86M 31.63% | 238.46M 1.10% | 63.872M -73.21% | |
| Operating Margin | N/A | N/A | -25,511.63% | -926.68% | -266.30% | -18.60% | 29.71% | 54.95% | 67.53% | 75.18% | 71.42% | 57.43% | |
| EPS YoY % growth | -1.09 -3.75% | -1.11 -1.83% | -0.40 63.96% | -0.32 19.04% | -0.26 20.47% | -0.05 81.52% | 0.22 571.39% | 1.00 347.73% | 2.05 103.55% | 2.47 20.70% | 2.44 -1.03% | 0.54 -77.87% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 37.23% | -0.08 -2.00% | -0.10 -27.50% | -0.10 -27.50% | -0.10 -25.00% |
| Revenue Q2Q % growth | 428.145K 895.69% | 655.523K 232.75% | 1.071M 153.79% | 1.301M 389.10% | 1.734M 305.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.166M -20.30% | -3.176M -2.13% | -4.154M -55.13% | -4.391M -37.21% | -4.406M -39.16% |
All data in USD
10 analysts have analysed RNXT and the average price target is 6.89 USD. This implies a price increase of 708.38% is expected in the next year compared to the current price of 0.8517.
RENOVORX INC (RNXT) will report earnings on 2026-04-01, before the market open.
The consensus EPS estimate for the next earnings of RENOVORX INC (RNXT) is -0.08 USD and the consensus revenue estimate is 428.14K USD.
The number of analysts covering RENOVORX INC (RNXT) is 10.